Process change evaluation framework for allogeneic cell therapies: impact on drug development and commercialization. (2016)
Attributed to:
EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2217/rme-2015-0034
PubMed Identifier: 26979513
Publication URI: http://europepmc.org/abstract/MED/26979513
Type: Journal Article/Review
Volume: 11
Parent Publication: Regenerative medicine
Issue: 3
ISSN: 1746-0751